» Articles » PMID: 20030990

Visceral Leishmaniasis in Aba-Roba, South-western Ethiopia: Prevalence and Incidence of Active and Subclinical Infections

Overview
Date 2009 Dec 25
PMID 20030990
Citations 49
Authors
Affiliations
Soon will be listed here.
Abstract

Between August 1997 and February 2005, a prospective study of human visceral leishmaniasis (VL) was undertaken in two villages in the Konso district of south-western Ethiopia, to provide epidemiological indices of subclinical infection and active VL. Six cross-sectional surveys at 6-month intervals (ending in August 2000) were complemented by a single survey in February 2005. The prevalences and incidences of leishmanial infection and active VL, which were determined using leishmanin skin tests (LST), direct agglutination tests (DAT) and parasitological diagnosis, varied spatio-temporally and by age and gender. At baseline, when 1339 individuals were investigated, the overall prevalences of LST positivity, DAT positivity and active VL among the 1232 subjects who had not been treated previously were 30.0%, 5.4% and 0.49%, respectively. During the study, <10% of the subjects found DAT-positive at baseline progressed to active VL (with a mean of about nine cases of subclinical infection for every one of active VL). The median age of an incident VL case was 10.5 years. The highest rates of LST conversion occurred among the subjects aged 5-25 years. A subject who became LST-positive during the study was much less likely to develop active VL than the other subjects.

Citing Articles

Prevalence of asymptomatic Leishmania donovani infection and associated factors in Ethiopia: a systematic review and meta-analysis.

Belay H, Abera A, Aklilu E, Bishaw T, Alemu A, Tasew G BMC Infect Dis. 2025; 25(1):78.

PMID: 39825258 PMC: 11748600. DOI: 10.1186/s12879-024-10275-6.


Prediction of visceral leishmaniasis development in a highly exposed HIV cohort in Ethiopia based on Leishmania infection markers: results from the PreLeisH study.

van Griensven J, van Henten S, Kibret A, Kassa M, Beyene H, Abdellati S EBioMedicine. 2024; 110:105474.

PMID: 39612653 PMC: 11647465. DOI: 10.1016/j.ebiom.2024.105474.


A mathematical model of visceral leishmaniasis transmission and control: Impact of ITNs on VL prevention and elimination in the Indian subcontinent.

Davis C, Javor E, Rebarber S, Rychtar J, Taylor D PLoS One. 2024; 19(10):e0311314.

PMID: 39365771 PMC: 11452004. DOI: 10.1371/journal.pone.0311314.


Medicinal plants with promising antileishmanial activity in Ethiopia: A systematic review and meta-analysis.

Worku K, Asfaw B, Mamo D, Haile Y, Tesfa H, Aemero M Medicine (Baltimore). 2024; 103(22):e38480.

PMID: 39259058 PMC: 11142835. DOI: 10.1097/MD.0000000000038480.


First report of cutaneous leishmaniasis caused by Leishmania donovani in Ethiopia.

Amare G, Mekonnen G, Kassa M, Addisu A, Kendie D, Tegegne B Parasit Vectors. 2023; 16(1):457.

PMID: 38104111 PMC: 10725588. DOI: 10.1186/s13071-023-06057-9.